FDA-Drug2023-05-03Class II
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Northwind Pharmaceuticals LLC
Hazard
CGMP Deviations
Sold states
Nationwide with the United States
Affected count
a) 230 bottles; b) 22 bottles
Manufactured in
4838 Fletcher Ave Ste 1000, N/A, Indianapolis, IN, United States
Products
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0551-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief